MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.495
-0.005 (-0.11%)
Aug 31, 2026, 3:11 PM EDT - Market open
MiMedx Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 655 | 1,003 | 1,414 | 1,020 | 316 | 671 | |
Market Cap Growth | -38.24% | -29.07% | 38.53% | 223.41% | -52.94% | -31.32% |
Enterprise Value | 537 | 879 | 1,344 | 1,083 | 391 | 726 |
Last Close Price | 4.50 | 6.77 | 9.62 | 8.77 | 2.78 | 6.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 106.34 | 20.64 | 33.33 | 21.91 | - | - |
Forward PE | 179.20 | 21.61 | 32.89 | 35.08 | 12.67 | 12.67 |
PS Ratio | 1.83 | 2.40 | 4.05 | 3.17 | 1.18 | 2.77 |
PB Ratio | 3.04 | 3.91 | 7.32 | 7.15 | 4.24 | 7.24 |
P/TBV Ratio | 3.52 | 4.50 | 8.72 | 8.65 | - | - |
P/FCF Ratio | 14.61 | 13.74 | 21.91 | 41.17 | - | - |
P/OCF Ratio | 14.09 | 13.55 | 21.35 | 38.11 | - | - |
PEG Ratio | - | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.50 | 2.10 | 3.85 | 3.37 | 1.46 | 3.00 |
EV/EBITDA Ratio | 26.04 | 11.16 | 20.56 | 26.70 | - | - |
EV/EBIT Ratio | 60.72 | 13.76 | 22.66 | 29.17 | - | - |
EV/FCF Ratio | 11.94 | 12.04 | 20.83 | 43.68 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.09 | 0.13 | 0.36 | 0.70 | 0.58 |
Debt / EBITDA Ratio | 0.78 | 0.28 | 0.37 | 1.23 | - | - |
Debt / FCF Ratio | 0.39 | 0.31 | 0.39 | 2.08 | - | - |
Net Debt / Equity Ratio | -0.55 | -0.56 | -0.41 | -0.21 | -0.18 | -0.36 |
Net Debt / EBITDA Ratio | -5.81 | -1.82 | -1.22 | -0.75 | 1.26 | 18.62 |
Net Debt / FCF Ratio | -2.67 | -1.97 | -1.23 | -1.23 | 0.69 | 6.50 |
Asset Turnover | 1.24 | 1.38 | 1.39 | 1.57 | 1.49 | 1.24 |
Inventory Turnover | 3.28 | 2.97 | 2.68 | 3.20 | 3.93 | 3.64 |
Quick Ratio | 4.60 | 3.76 | 3.52 | 2.95 | 2.50 | 3.03 |
Current Ratio | 5.33 | 4.32 | 4.21 | 3.57 | 3.08 | 3.51 |
Return on Equity (ROE) | 2.88% | 21.61% | 25.01% | 62.09% | -23.88% | -13.37% |
Return on Assets (ROA) | 1.91% | 13.17% | 14.74% | 11.30% | -5.12% | -2.24% |
Return on Invested Capital (ROIC) | 4.78% | 41.36% | 38.51% | 42.84% | -24.58% | -13.18% |
Return on Capital Employed (ROCE) | 3.60% | 22.90% | 27.20% | 19.20% | -11.50% | -4.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.96% | 4.84% | 3.00% | 5.71% | -9.57% | -1.53% |
FCF Yield | 6.85% | 7.28% | 4.56% | 2.43% | -6.15% | -0.78% |
Buyback Yield / Dilution | 0.13% | -0.45% | -2.11% | -29.27% | -2.32% | -1.94% |